Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Prognostic Significance of the Percentage of Blasts with CD34+/CD38low/-/CD123+ Phenotype in Acute Myeloid Leukemias].

Zhongguo shi yan xue ye xue za zhi - 1 Feb 2017

Xiang Li-Li, Qiu Guo-Qiang, Xie Xiao-Bao, Cen Jian-Nong, Hu Shao-Yan, Gu Wei-Ying

Abstract excerpt

OBJECTIVE: To investigate the percentage of blasts with the CD34+/CD38low/-/CD123+ phenotype in de novo acute myeloid leukemia (AML) patients and analyse its correlation with prognosis. METHODS: The percentage of CD34+/CD38low/-/CD123+ cells in the blast population of 148 newly diagnosed patients with AML was determined by using flow cytometry and its correlation with complete response, disease-free survival and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to Antigens, CD34

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to FLT3 gene

Share to NPM1 gene

Share to Leukemia, Myeloid, Acute

Share to Nucleophosmin

Share to Phenotype

Share to Prognosis

Source

Identifiers

PMID: 28245376
DOI: 10.7534/j.issn.1009-2137.2017.01.010

Genes

FLT3
NPM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Prognostic Significance of the Percentage of Blasts with CD34+/CD38low/-/CD123+ Phenotype in Acute Myeloid Leukemias].PMID 28245376Read ↗

CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.Semantic proximity Read ↗

[Prognostic Value of CD123 in Acute Myeloid Leukemia Patients with Intermediate Risk in Normal Karyotype].Semantic proximity Read ↗

Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.Semantic proximity Read ↗

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.Semantic proximity Read ↗

Prognostic relevance of CD123 expression in adult AML with normal karyotypeSemantic proximity Read ↗

Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.Semantic proximity Read ↗

High proportion of CD34+/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

CD123 Is Consistently Expressed on NPM1-Mutated AML CellsSemantic proximity Read ↗

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid LeukemiaSemantic proximity Read ↗

Detection of molecular targets on the surface of CD34<sup>+</sup>CD38<sup>−</sup> bone marrow cells in myelodysplastic syndromesSemantic proximity Read ↗

[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia].Semantic proximity Read ↗

Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.